{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:51:58Z","timestamp":1793109118494,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40272-022-00550-x","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T01:02:19Z","timestamp":1671066139000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Sodium Thiosulfate: Pediatric First Approval"],"prefix":"10.1007","volume":"25","author":[{"given":"Sohita","family":"Dhillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"8","key":"550_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2352-4642(19)30115-4","volume":"3","author":"DR Freyer","year":"2019","unstructured":"Freyer DR, Brock P, Knight K, et al. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer. Lancet Child Adolesc Health. 2019;3(8):578\u201384.","journal-title":"Lancet Child Adolesc Health."},{"issue":"2","key":"550_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2352-4642(19)30336-0","volume":"4","author":"DR Freyer","year":"2020","unstructured":"Freyer DR, Brock PR, Chang KW, et al. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline. Lancet Child Adolesc Health. 2020;4(2):141\u201350.","journal-title":"Lancet Child Adolesc Health."},{"key":"550_CR3","unstructured":"US FDA. PEDMARK\u00ae (sodium thiosulfate injection): US prescribing information. 2022. https:\/\/pedmark.com\/wp-content\/uploads\/2022\/09\/pedmark-pi.pdf. Accessed 7 Nov 2022."},{"key":"550_CR4","unstructured":"US FDA. FDA approves sodium thiosulfate to reduce the risk of ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors. 2022. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-sodium-thiosulfate-reduce-risk-ototoxicity-associated-cisplatin-pediatric-patients. Accessed 7 Nov."},{"key":"550_CR5","unstructured":"Fennec Pharmaceuticals Inc. Annual report. 2021. https:\/\/www.sec.gov\/Archives\/edgar\/data\/1211583\/000110465921043756\/tm21107d1_10k.htm. Accessed 8 Nov 2022."},{"issue":"3","key":"550_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1124\/jpet.105.087601","volume":"314","author":"DT Dickey","year":"2005","unstructured":"Dickey DT, Wu YJ, Muldoon LL, et al. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther. 2005;314(3):1052\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"550_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1158\/1078-0432.CCR-06-2289","volume":"14","author":"TM Harned","year":"2008","unstructured":"Harned TM, Kalous O, Neuwelt A, et al. Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity. Clin Cancer Res. 2008;14(2):533\u201340.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"550_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","volume":"18","author":"DR Freyer","year":"2017","unstructured":"Freyer DR, Chen L, Krailo MD, et al. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017;18(1):63\u201374.","journal-title":"Lancet Oncol"},{"issue":"5","key":"550_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1470-2045(22)00155-3","volume":"23","author":"E Orgel","year":"2022","unstructured":"Orgel E, Villaluna D, Krailo MD, et al. Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431. Lancet Oncol. 2022;23(5):570\u20132.","journal-title":"Lancet Oncol"},{"issue":"25","key":"550_CR10","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","volume":"378","author":"PR Brock","year":"2018","unstructured":"Brock PR, Maibach R, Childs M, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med. 2018;378(25):2376\u201385.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00550-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-022-00550-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00550-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T19:06:23Z","timestamp":1676487983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-022-00550-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s40272-022-00550-x","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"15 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Sohita Dhillon is a contracted employee of Adis International Ltd\/Springer Nature and declares no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship and Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability"}}]}}